Myeloma Minute: IMF at ASH 2019


| INNOVATION | Latest Research


IMF Presents Research, Video Reports, Social Media Coverage at 2019 American Society of Hematology (ASH) Meeting

The International Myeloma Foundation (IMF) announced that four important research studies supported by the organization's Black Swan Research Initiative® (BSRI) to find a cure for multiple myeloma will be presented at the American Society of Hematology (ASH) annual meeting in Orlando, Dec. 7-10. Learn more about how the IMF activities at ASH 2019 highlight the strength of the organization’s four pillars: myeloma research, patient education, patient support, and patient advocacy. You can also find the IMF at ASH at Booth 2006.


| INNOVATION | Livestream


Tune into Approaches To Achieve the Best Possible Outcomes in Myeloma

Join this webinar with a panel of international experts. They will discuss practice-changing data and optimal management of patients with myeloma. Mark your calendar for Friday, December 6, 2019, at 1:00 p.m. PT / 2:00 p.m. CT / 4:00 p.m. ET for this livestream. The expert panel includes Drs. Brian G.M. Durie, Shaji Kumar, Thomas G. Martin, Philippe Moreau, S. Vincent Rajkumar, and Jesús F. San-Miguel.


| INSPIRATION | Holiday Shopping


| EDUCATION | Myeloma Today


When You Shop Amazon Smile, Choose the IMF as Your Charity
Hot Off the Press: The Fall 2019 Edition of Myeloma Today!

You are probably already busy doing your holiday shopping. Why not select the International Myeloma Foundation as your preferred charity from This way every time you shop, Amazon gives to the IMF. It is all at no added cost to you—the gift of choice!

Available as a free download or printed copy. Read about Great Debates in Myeloma at the 17th IMW, the role of selinexor in penta-refractory myeloma, melflufen in clinical trials, and the IMF’s 13th Annual Comedy Celebration! Medical articles are translated and available in French, Italian, German and Spanish.



| INSPIRATION | Patient Voices


Read Blogs from Patients and Caregivers Attending ASH 2019

Once again, the IMF hosts myeloma support group leaders and patients at the annual meeting of the American Society of Hematology (ASH). Learn about the latest updates in myeloma research and treatment strategies from the patient perspective!


| INNOVATION | IMWG Conference Series


Save the Date: IMWG Conference Series Livestream on Monday, December 9

Watch the IMF's popular livestream IMWG Conference Series, "Making Sense of Treatment" from Orlando. Save the date: Monday, December 9, 2019, at 5:30 p.m. PT / 7:30 p.m. CT / 8:30 p.m. ET. IMF Chairman Dr. Brian G.M. Durie, Dr. María V. Mateos, and IMF Chief Medical Officer Dr. Joseph Mikhael distill, debate, and discuss the latest news and trends in the treatment of multiple myeloma from the 61st Annual ASH Meeting.


| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series



Search the Myeloma Matrix 2.0

Join the conversation about myeloma on the Smart Patients Message Board

Clinical Trial Fact Sheets

OCEAN Trial (Now Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

December 6, 2019
ASH Satellite Symposium

December 9, 2019
IMWG Conference Series: ASH 2019

January 10, 2020
Magical Miles for Myeloma
Walt Disney World - Orlando

March 13-14, 2020
IMF Patient & Family Seminar
Boca Raton, FL

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Celgene Corporation, Genentech, and Takeda Oncology

We also thank individuals like you for your continued support!

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.